Aliskiren increases the half-life of renin and prorenin and alters prorenin conformation, explaining the renin surge seen during treatment without leading to angiotensin generation.
No takes yet. Share an insight, caveat, or question.
May explain clinical renin surge without angiotensin generation; leaves open relevance in humans pending validation.
Batenburg et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: